HCMHUTCHMED (China) Limited
What is the market doing?
No clear lean: rangebound and a token position.
Choppy, but holding above its 200-day average. Price is +5% vs its 200-day average.
A token position, settled Sep 15, 2026, a few days of normal trading to cover. Up 14% since the previous count, unchanged over three months.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How HCM is trading
HUTCHMED (China) Limited is −18% over the past year while the S&P 500 is +18%: 36 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +4.8%
vs 200-day average · close to trend
- RSI (14)
- 44
RSI (14) · neutral
- Below its 52-week high
- 16%
Below its 52-week high
Details›
- Last close2026-10-09
- $14.04
- 1 monthS&P 500 +2.7%
- +7.2%
- 1 yearS&P 500 +18%
- −18%
- 5 yearsS&P 500 +88%
- −64%
- vs 50-day average$13.10
- +7.2%
- 52-week high
- $16.66
- 52-week low
- $9.99
- Annualised volatility
- 49%
| Year | Return |
|---|---|
| 2026 (year to date) | +5.3% |
| 2025 | −7.5% |
| 2024 | −20% |
| 2023 | +23% |
| 2022 | −58% |
| 2021 | +9.6% |
| 2020 | +28% |
| 2019 | +8.6% |
| 2018 | −41% |
| 2017 | +190% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 3 of 10 | −3.1% |
| Feb | 10 | 4 of 10 | +1.1% |
| Mar | 10 | 4 of 10 | −0.85% |
| Apr | 10 | 5 of 10 | +2.7% |
| May | 10 | 4 of 10 | −8.0% |
| Jun | 10 | 6 of 10 | +6.2% |
| Jul | 11 | 7 of 11 | +5.6% |
| Aug | 11 | 5 of 11 | +1.00% |
| Sep | 11 | 6 of 11 | +0.32% |
| Oct | 11 | 5 of 11 | −1.1% |
| Nov | 10 | 7 of 10 | +11% |
| Dec | 10 | 5 of 10 | −1.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #38 of 41 by RyuScore